Sponsor overview

Shayna Sarosiek, MD

Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.

Back to report

Summary

Signal counts

Assets tracked: 1

Watchlist assets: 1

Registry stop assets: 1

Evidence links

Public sources

https://clinicaltrials.gov/study/NCT05190705 | https://clinicaltrials.gov/study/NCT06788964 | https://clinicaltrials.gov/study/NCT05144009 | https://clinicaltrials.gov/study/NCT04998669 | https://clinicaltrials.gov/study/NCT05453396 | https://clinicaltrials.gov/study/NCT03684694

Assets

Linked programs

Loncastuximab Tesirine: Registry Stop Signal (4/5)